Navigation Links
IntraLinks Poll: Half of Clinical Trial Management Professionals Share Critical Information Via E-Mail
Date:1/26/2009

NEW YORK, Jan. 26 /PRNewswire/ -- Fifty percent of clinical trial management professionals in the life sciences industry still share high-value, proprietary company information via e-mail, while others do so via fax (15 percent) or overnight courier (14 percent), according to a recent IntraLinks(R) poll.

Respondents who were considering web-based solutions for exchanging clinical trial information with outside parties indicated their primary concerns were security (40 percent), ease and flexibility of use (23 percent), speed of information sharing (17 percent), standardization across the enterprise (7 percent) and shipping/travel cost savings (7 percent).

In addition, respondents indicated that the greatest challenges they face when starting a new study or clinical trial are getting research sites onboard quickly (61 percent); reducing cycle time (22 percent); and exchanging information with all sites efficiently (12 percent).

"Executives may not realize that study start-up communication and management can be made simpler, faster and more secure by employing online solutions," said Alison Shurell, vice president of life sciences product marketing for IntraLinks. "Using an online workspace enables sponsors, CROs, sites, IRBs and others in a clinical trial to exchange information instantaneously in the most secure environment available. Our life sciences clients who have shifted the clinical trial process to an online solution have reported tremendous improvements in overall productivity and efficiency."

More than 50 executives from pharmaceutical, biotechnology, medical device and healthcare companies and CROs responded to polling questions for a recent webcast titled "Site Activation: How to Reduce Costs and Shorten Study Start-up Time." Sixty three percent of the polling respondents are involved in the management of clinical trials for their companies.

Executives from
'/>"/>

SOURCE IntraLinks
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy.  The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board.  In this study, INS001 appeared safe and ...
(Date:5/17/2013)... 17, 2013 RURO Inc. is ... 4.1, a versatile refinement to the smart management ... improves its advanced methodical management for transgenic animal ... 4.1. The network-based platform provides user access with ... While continuing to emphasize streamlined tasks, such as ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Tooth decay is ... showing active signs of the disease. The World Health Organization ... nearly 100% of adults have cavities. What are the long-term ... is showing a strong connection between the oral bacterial imbalance ... this disease so rampant, yet it is also 100% preventable? ...
(Date:5/16/2013)... Oven Industries, Inc. has been an industry ... sensors since 1964. Expertly designed, the proportional-integral-derivative PID ... applications. As one of the most commonly ... loop feedback system, which helps minimize errors. With three-term ... systematic process, using a control element, like a valve ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3New PID Temperature Controllers Announced by Oven Industries Inc. 2
... (Infectious Disease Research,Institute) and Immune Design Corp. announced ... to which Immune Design Corp. is granted a ... of,IDRI,s Glycopyranosyl Lipid Adjuvant (GLA) technology for products ... to fight infectious diseases of,the developing world, IDRI ...
... WWMR, Inc., the marketing research,leader in pain, ... Pain,Drug Company Survey". The top three most ... according to the 100 pain clinic,physicians surveyed in ... for,their knowledgeable, respectful and informed sales representatives, their,sampling/voucher ...
... 20 A US District Court,judge in Oregon yesterday ... & Nephew,s (NYSE: SNN ; LSE: SN) ... of Naples, Fla., from manufacturing or,selling medical devices that ... Dr. John O. Hayhurst of Portland, Ore. The ...
Cached Biology Technology:IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 3US District Court Enters Final Judgment in Favor of Smith & Nephew; Permanent Injunction Prohibits Arthrex Inc. From Selling Infringing Medical Devices 2US District Court Enters Final Judgment in Favor of Smith & Nephew; Permanent Injunction Prohibits Arthrex Inc. From Selling Infringing Medical Devices 3
(Date:5/17/2013)... The State University of New Jersey, and City University ... called Visikol TM that effectively clears organisms to ... place of chloral hydrate, which is one of the ... tightly regulated by the Drug Enforcement Administration (DEA) due ... or clearing agents, are vital for viewing organisms under ...
(Date:5/17/2013)... project (Intelligent Cargo in Efficient and Sustainable Global Logistics ... an improvement in the efficiency of intermodal loading systems ... making. It comprises 29 European organisations with experience in ... has a budget totalling 17,000,000 and a duration of ... to specify and develop the semantic components and ontologies ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... often get bad press, with those found in water ... The University of Nottingham are using these tiny organisms ... and refine water cleaning technology. These one-celled organisms ... is being treated prior to industrial use or even ...
... Think of bacteria eating rock. Now think of bacteria ... on bacteria in that rock 15,000 feet underwater" ... Betty Moore Foundation, USC researcher Katrina Edwards will lead ... Recently discovered subseafloor microbes, which live on chemical ...
... being launched today to tackle some of the most ... which can devastate crop yields across the developing world. ... live in rural areas and most depend on agriculture ... through higher incomes, more and cheaper food, and more ...
Cached Biology News:Bacteria and nanofilters -- the future of clean water technology 2USC awarded $3.9M for lab under the sea 2Major scientific push to tackle agricultural productivity and food security in developing world 2Major scientific push to tackle agricultural productivity and food security in developing world 3
BD BioCoat Collagen I 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I....
Topoisomerase II...
... a positive selection for creating baculovirus recombinants ... insect cells. The kit improves on the ... eliminating the time-consuming steps of plaque purification. ... with a portion of the essential open ...
... The CHEMICON XpressPack™ Colorimetric Detection System ... detection of amplified DNA generated by an ... of a selected target of interest. ... Colorimetric Detection System is a hybridization capture ...
Biology Products: